A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation

Key Points • RUNX1 governs the direct differentiation potential of MK-HSCs into MKs.• RUNX1 binds to and regulates MK developmental genes in MK-HSCs.

[1]  Y. Qi,et al.  Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2. , 2021, Blood.

[2]  C. Preudhomme,et al.  Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications , 2021, Expert opinion on therapeutic targets.

[3]  J. A. Maguire,et al.  Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation. , 2021, Blood advances.

[4]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[5]  Nicola K. Wilson,et al.  CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation , 2020, Proceedings of the National Academy of Sciences.

[6]  Allon M. Klein,et al.  Single-cell lineage tracing unveils a role for Tcf15 in haematopoiesis , 2020, Nature.

[7]  A. Cantor,et al.  Role of RUNX Family Transcription Factors in DNA Damage Response , 2020, Molecules and cells.

[8]  Michael R. Green,et al.  RUNX1 targeted therapy for AML expressing somatic or germline mutation in RUNX1. , 2019, Blood.

[9]  Alireza Hadj Khodabakhshi,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[10]  M. Fleming,et al.  Bone Marrow Morphology Associated With Germline RUNX1 Mutations in Patients With Familial Platelet Disorder With Associated Myeloid Malignancy , 2019, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[11]  Lai Guan Ng,et al.  Dimensionality reduction for visualizing single-cell data using UMAP , 2018, Nature Biotechnology.

[12]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[13]  M. Caligiuri,et al.  Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes. , 2018, Cancer discovery.

[14]  M. Socolovsky,et al.  High-throughput single-cell fate potential assay of murine hematopoietic progenitors in vitro. , 2018, Experimental hematology.

[15]  S. Henikoff,et al.  Targeted in situ genome-wide profiling with high efficiency for low cell numbers , 2018, Nature Protocols.

[16]  A. Cantor.  Choosing wisely: RUNX1 alternate promoter use. , 2017, Blood.

[17]  Salam A. Assi,et al.  RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML , 2017, Cell reports.

[18]  R. Sood,et al.  Role of RUNX1 in hematological malignancies. , 2017, Blood.

[19]  D. Bryder,et al.  Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis , 2016, Stem cell reports.

[20]  Takashi Yamamoto,et al.  Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis. , 2015, Experimental hematology.

[21]  Long Gao,et al.  Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells. , 2015, Cell stem cell.

[22]  Fabian J. Theis,et al.  Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations , 2015, Cell stem cell.

[23]  C. Eaves.  Hematopoietic stem cells: concepts, definitions, and the new reality. , 2015, Blood.

[24]  Xi C. He,et al.  Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells , 2014, Nature Medicine.

[25]  Ming Yan,et al.  Hmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice. , 2014, Blood.

[26]  E. Kwon,et al.  Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects. , 2014, Blood.

[27]  I. Macaulay,et al.  Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy , 2013, Nature.

[28]  T. Graf,et al.  CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. , 2013, Blood.

[29]  A. Tanay,et al.  Cell-Autonomous Function of Runx1 Transcriptionally Regulates Mouse Megakaryocytic Maturation , 2013, PloS one.

[30]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[31]  N. Aghaeepour,et al.  Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. , 2012, Cell stem cell.

[32]  D. Tenen,et al.  The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. , 2011, Blood.

[33]  J. Gaudet,et al.  Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells , 2011, PloS one.

[34]  Verena I Gaidzik,et al.  RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  G. Swiers,et al.  Hematopoietic stem cell emergence in the conceptus and the role of Runx1. , 2010, The International journal of developmental biology.

[36]  H. Nakauchi,et al.  Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment , 2010, The Journal of experimental medicine.

[37]  Nathan C Boles,et al.  Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. , 2010, Cell stem cell.

[38]  A. Cantor,et al.  Common features of megakaryocytes and hematopoietic stem cells: What's the connection? , 2009, Journal of cellular biochemistry.

[39]  H. Harada,et al.  Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations , 2009, Journal of cellular physiology.

[40]  B. Leber,et al.  Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. , 2008, Blood.

[41]  T. Era,et al.  AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells* , 2008, Journal of Biological Chemistry.

[42]  Matthew E Ritchie,et al.  Integrative analysis of RUNX1 downstream pathways and target genes , 2008, BMC Genomics.

[43]  S. Ogawa,et al.  This information is current as Hematopoiesis Hematopoietic Stem Cells in Adult AML 1 / Runx 1 Negatively Regulates Quiescent , 2008 .

[44]  Caroline L. Speck,et al.  Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. , 2007, Blood.

[45]  David Bryder,et al.  Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. , 2007, Cell stem cell.

[46]  Ryan Brinkman,et al.  Long-term propagation of distinct hematopoietic differentiation programs in vivo. , 2007, Cell stem cell.

[47]  M. Weiss,et al.  Megakaryocyte biology and related disorders. , 2005, The Journal of clinical investigation.

[48]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[49]  J. Downing,et al.  Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors. , 2004, Blood.

[50]  J. Kutok,et al.  Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. , 2004, Blood.

[51]  G. Assmann,et al.  Impaired Platelet Activation in Familial High Density Lipoprotein Deficiency (Tangier Disease)* , 2004, Journal of Biological Chemistry.

[52]  Motomi Osato.  Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia , 2004, Oncogene.

[53]  S. Ogawa,et al.  AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis , 2004, Nature Medicine.

[54]  C. Matheny,et al.  Runx1 Is Expressed in Adult Mouse Hematopoietic Stem Cells and Differentiating Myeloid and Lymphoid Cells, But Not in Maturing Erythroid Cells , 2004, Stem cells.

[55]  Kamaleldin E Elagib,et al.  RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. , 2003, Blood.

[56]  H. Sieburg,et al.  Deterministic regulation of hematopoietic stem cell self-renewal and differentiation. , 2002, Blood.

[57]  T. Graf.  Differentiation plasticity of hematopoietic cells. , 2002, Blood.

[58]  J. Licht.  AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML , 2001, Oncogene.

[59]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[60]  J. Lotem,et al.  Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation , 1998, Cell Death and Differentiation.

[61]  M. Marín‐Padilla,et al.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[62]  H. Bengtsson,et al.  Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome , 2010, Leukemia.

[63]  Y. Okuno,et al.  PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis , 2008, Nature Genetics.

[64]  K. Miyazono,et al.  RUNX transcription factors as key targets of TGF-beta superfamily signaling. , 2003, Current opinion in genetics & development.

[65]  D. Jamison,et al.  Studies of a familial platelet disorder. , 1985, Blood.